Polarean Imaging (GB:POLX) has released an update.
Polarean Imaging PLC has successfully completed a fundraising effort, securing $10 million through a combined placement and subscription strategy that included significant investments from key shareholders NUKEM Isotopes GmbH and Bracco Imaging S.p.A. The funds will be used to accelerate the commercialization of the company’s XENOVIEW product, further R&D, and general corporate purposes. Shareholders also have the opportunity to participate in an open offer to potentially raise an additional $2.5 million.
For further insights into GB:POLX stock, check out TipRanks’ Stock Analysis page.
